La Jolla, CA, United States of America

Marguerita S Lim-Wilby

USPTO Granted Patents = 14 

Average Co-Inventor Count = 8.2

ph-index = 8

Forward Citations = 332(Granted Patents)


Location History:

  • La Jolla, CA (US) (1997 - 2009)
  • Santa Fe, NM (US) (2012)

Company Filing History:


Years Active: 1997-2012

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Inventive Journey of Marguerita S Lim-Wilby

Introduction:

Marguerita S Lim-Wilby, a prolific inventor based in La Jolla, CA, has made significant contributions to the field of pharmaceuticals with a total of 14 patents to his name. His groundbreaking work in developing peptides as NS3-serine protease inhibitors for the treatment of hepatitis C virus is revolutionizing the landscape of antiviral therapies.

Latest Patents:

Lim-Wilby's latest patents focus on the development of novel peptide compounds with HCV protease inhibitory activity. These inventions not only include the compounds themselves but also encompass methods for their preparation and pharmaceutical compositions incorporating these peptides. The potential impact of these patents is immense, offering new avenues for treating disorders associated with the HCV protease.

Career Highlights:

Throughout his career, Lim-Wilby has been associated with esteemed companies such as Corvas International, Inc. and Schering Corporation. His expertise and innovative spirit have propelled him to the forefront of pharmaceutical research, where his work continues to shape the future of antiviral treatments.

Collaborations:

In his quest for scientific excellence, Marguerita S Lim-Wilby has collaborated with notable peers in the industry. Among his coworkers are Terence Kevin Brunck and Joseph Edward Semple, individuals who have contributed to the collective efforts aimed at advancing antiviral therapies and drug development.

Conclusion:

Marguerita S Lim-Wilby's journey as an inventor underscores the vital role of innovation in the pharmaceutical sector. His patents stand as a testament to his dedication to scientific discovery and his commitment to improving healthcare outcomes. Through his continued contributions, Lim-Wilby is paving the way for enhanced treatments for hepatitis C and other related conditions, leaving an indelible mark on the field of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…